Doximity, Inc.
DOCSNYSETechnology · Services-Computer Programming Services · DE · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY26 | FY25 | FY24 | FY23 | FY22 | FY21 | |
|---|---|---|---|---|---|---|
| Revenue | $644.9M | $570.4M | $475.4M | $419.1M | $343.5M | $206.9M |
| Operating income | $214.9M | $227.8M | $163.9M | $125.1M | $113.5M | $53.3M |
| Net income | $196.1M | $223.2M | $147.6M | $112.8M | $154.8M | $50.2M |
| Total assets | $1.12B | $1.26B | $1.08B | $1.14B | $991.4M | $251.7M |
| Total liabilities | $172.8M | $181.7M | $178.0M | $170.8M | $112.8M | $103.5M |
| Equity | $950.8M | $1.08B | $901.4M | $966.1M | $878.6M | $66.7M |
| EPS (diluted) | $0.98 | $1.11 | $0.72 | $0.53 | $0.70 | $0.23 |
| Shares out. | 183.1M | 188.9M | 186.6M | 193.9M | 192.4M | 82.9M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2026- Operating margin
- 33.3%
- Net margin
- 30.4%
- Return on equity
- 20.6%
- Return on assets
- 17.4%
- Return on capital (ROCE)
- 22.2%
- Liabilities / assets
- 15.4%
- Debt / equity
- 0.18×
- Book value / share
- $5.19
- Revenue growth (YoY)
- 13.1%
- Net income growth (YoY)
- −12.2%
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2026- Altman Z″ (distress)
- 11.52safe
- Accruals / assets
- −11.6%clean
- Beneish M-Score
- -2.92normal
- Piotroski F-Score
- 5/9mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 7 good- Operating margin is positive
- Strong return on equity (>15%)
- Revenue is growing year-over-year
- Conservative leverage (liabilities < 50% of assets)
- Positive operating cash flow
- Clean earnings (low accruals)
- Altman Z″ in the safe zone
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Tangney JeffreyPassive (13G)May 15, 2026
- Vanguard Capital Management LlcPassive (13G)Apr 29, 2026
- Vanguard Group IncPassive (13G)Mar 26, 2026
- Fmr LlcPassive (13G)Feb 5, 2026
- Durable Capital Partners LpPassive (13G)Feb 14, 2025
- Emergence Capital Partners Ii LpPassive (13G)Feb 13, 2025
- William Blair Investment Management, LlcPassive (13G)Feb 12, 2025
- Clearbridge Investments, LlcPassive (13G)Oct 31, 2024
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 15.7M | 2.3 | -7.8% |
| Apr 30, 2026 | 17.0M | 5.4 | +12.9% |
| Apr 15, 2026 | 15.1M | 5.0 | +14.1% |
| Mar 31, 2026 | 13.2M | 4.9 | +3.2% |
| Mar 13, 2026 | 12.8M | 4.9 | +18.4% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Results of operations · Director / officer changeMay 13, 2026
- Director / officer change · Regulation FD disclosureApr 17, 2026
- Results of operations · Director / officer changeFeb 5, 2026
- Other material eventDec 30, 2025
- Results of operationsNov 6, 2025
- Shareholder voteSep 2, 2025
- Director / officer changeAug 15, 2025
- Results of operationsAug 7, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- 4FORM 4May 19, 2026
- 4FORM 4May 19, 2026
- S-8May 19, 2026
- 10-KMay 19, 2026
- SCHEDULE 13G/AMay 15, 2026
- 4FORM 4May 13, 2026
- 8-KMay 13, 2026
- 144May 11, 2026
- 4FORM 4May 8, 2026
- 144May 7, 2026
- SCHEDULE 13GApr 29, 2026
- 8-KApr 17, 2026
- 4FORM 4Apr 14, 2026
- 144Apr 10, 2026
- SCHEDULE 13G/AMar 26, 2026